Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Silence Therapeutics PLC Sponsored ADR (NASDAQ: SLN - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven brokerages that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, four have issued a buy rating and one has assigned a strong